MAPT and neurodegenerative disease: In addition, individuals who are Aβ‐negative (Aβ–) often exhibit neurodegenerative disease‐related phenotypes, including tau pathology, accelerated cortical thinning, and progressive cognitive dysfunction.5, 6, 7